Clinical trial
Study Of Generalized Anxiety Disorder
NCT00135525 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00135525 |
|---|---|
| Title | Study Of Generalized Anxiety Disorder |
| Official title | Clinical Evaluation of BRL29060 A in Generalized Anxiety Disorder |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Anxiety Disorder, Anxiety Disorders |
| Intervention type | Drug |
| Interventions | Paroxetine, Placebo |
| Start date | May 1, 2003 |
| Primary completion | Oct 1, 2005 |
| Completion | May 1, 2006 |
| First posted | Aug 26, 2005 |
| Last update posted | Jan 31, 2011 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: